J Korean Med Sci.  2022 Jan;37(3):e31. 10.3346/jkms.2022.37.e31.

Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea

• Kim MK
• Lee B
• Choi YY
• Um J
• Lee KS
• Sung HK
• Kim Y
• Park JS
• Lee M
• Jang HC
• Bang JH
• Chung Kh
• Jeon J

• KMID: 2524893
• DOI: http://doi.org/10.3346/jkms.2022.37.e31

Abstract

Since severe acute respiratory syndrome-coronavirus-2 variant B.1.1.529 (omicron) was first reported to the World Health Organization on November 24, 2021, the cases of the omicron variant have been detected in more than 90 countries over the last month. We investigated the clinical and epidemiological characteristics of the first 40 patients with the omicron variant who had been isolated at the National Medical Center in South Korea during December 4–17, 2021. The median age of the patients was 39.5 years. Twenty-two patients (55%) were women. Seventeen patients (42.5%) were fully vaccinated, and none were reinfected with the omicron. Eighteen (45%) had recent international travel history. Half of the patients (19, 47.5%) were asymptomatic, while the others had mild symptoms. Six patients (15%) showed lung infiltrations on chest image; however, none required supplemental oxygen. These mild clinical features are consistent with recent case reports on the omicron variant from other countries.

Keyword

COVID-19; B.1.1.529 SARS-CoV-2 Variant; Cohort Studies; Republic of Korea

Reference

1. World Health Organization. Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern. Updated 2021. Accessed December 22, 2021. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern .

2. Ingraham NE, Ingbar DH. The omicron variant of SARS-CoV-2: understanding the known and living with unknowns. Clin Transl Med. 2021; 11(12):e685. PMID: 34911167.

3. UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England. Updated 2021. Accessed December 22, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1036501/Technical_Briefing_29_published_26_November_2021.pdf .

4. Dyer O. Covid-19: South Africa’s surge in cases deepens alarm over omicron variant. BMJ. 2021; 375(3013):n3013. PMID: 34862184.

5. ECDC. Assessment of the further emergence and potential impact of the SARS-CoV-2 omicron variant of concern in the context of ongoing transmission of the Delta variant of concern in the EU/EEA, 18th. Updated 15 December 2021. Updated 2021. Accessed December 22, 2021. https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-assessment-further-emergence-omicron-18th-risk-assessment-december-2021.pdf .

6. Lee JJ, Choe YJ, Jeong H, Kim M, Kim S, Yoo H, et al. Importation and transmission of SARS-CoV-2 B.1.1.529 (omicron) variant of concern in Korea, November 2021. J Korean Med Sci. 2021; 36(50):e346. PMID: 34962117.

7. World Health Organization. Omicron spreads but severe cases remain low in South Africa. Updated 2021. Accessed December 22, 2021. https://www.afro.who.int/news/omicron-spreads-severe-cases-remain-low-south-africa .

8. CDC COVID-19 Response Team. SARS-CoV-2 B.1.1.529 (omicron) variant - United States, December 1–8, 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(50):1731–1734. PMID: 34914670.

9. Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021; 398(10317):2126–2128. PMID: 34871545.